Enliven Therapeutics, Inc. ($ELVN)
Filing Information
| Accession Number | 0001967150-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 22, 2026 |
| Document Date | Jan 20, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
20,000
Total Value
$535,098.99
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF SCIENTIFIC OFFICER | Common Stock | โ | Jan 20, 2026 | Sale | 5,491 | $26.37 | $144,814.14 | 759,697 | Indirect | See footnote | View Details | |
CHIEF SCIENTIFIC OFFICER | Common Stock | โ | Jan 20, 2026 | Sale | 14,509 | $26.90 | $390,284.85 | 745,188 | Indirect | See footnote | View Details |